Stock analysts at Liberum Capital started coverage on shares of Concepta PLC (LON:FRI) in a research report issued to clients and investors on Tuesday, StockTargetPrices.com reports. The brokerage set a “buy” rating and a GBX 850 ($11.03) price target on the stock.

Several other analysts also recently issued reports on FRI. FinnCap upped their price objective on shares of Concepta PLC from GBX 500 ($6.49) to GBX 690 ($8.96) and gave the stock a “corporate” rating in a report on Friday, July 28th. Numis Securities Ltd raised shares of Concepta PLC to an “add” rating and upped their price objective for the stock from GBX 300 ($3.89) to GBX 466 ($6.05) in a report on Thursday, June 22nd. Finally, Peel Hunt upped their price objective on shares of Concepta PLC from GBX 114 ($1.48) to GBX 117 ($1.52) and gave the stock a “buy” rating in a report on Friday, May 5th.

TRADEMARK VIOLATION NOTICE: “Concepta PLC (LON:FRI) Coverage Initiated at Liberum Capital” was first posted by Watch List News and is owned by of Watch List News. If you are reading this story on another site, it was copied illegally and reposted in violation of U.S. & international trademark and copyright law. The original version of this story can be viewed at https://www.watchlistnews.com/concepta-plc-lonfri-coverage-initiated-at-liberum-capital/1488465.html.

Concepta PLC Company Profile

Concepta PLC, formerly Frontier Resources International Plc, is a healthcare company. The Company is involved in the development of products and a platform, which targets the personalized mobile health market with a focus on women’s fertility and unexplained infertility. The Company’s portfolio of products includes MyLotus Meter, Ovulation Test, Pregnancy Test and Fertility App.

Stock Target Prices

Receive News & Ratings for Concepta PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Concepta PLC and related companies with Analyst Ratings Network's FREE daily email newsletter.